Takeda Revenue and Competitors
Estimated Revenue & Valuation
- Takeda's estimated annual revenue is currently $200.6M per year.
- Takeda's estimated revenue per employee is $195,324
- Takeda's current valuation is $45.9B. (January 2022)
Employee Data
- Takeda has 1027 Employees.
- Takeda grew their employee count by 5% last year.
Takeda's People
Name | Title | Email/Phone |
---|---|---|
1 | VP PDD Global Quality Systems | Reveal Email/Phone |
2 | Neuroscience Sales Specialist | Reveal Email/Phone |
3 | West Regional Director, Field Reimbursement | Reveal Email/Phone |
4 | Specialty District Manager, Neuroscience | Reveal Email/Phone |
5 | Specialty District Manager | Reveal Email/Phone |
6 | Assistant Corporate Controller | Reveal Email/Phone |
7 | Sr. Patient Support Manager | Reveal Email/Phone |
8 | Systems Engineer | Reveal Email/Phone |
9 | Immunology Specialist | Reveal Email/Phone |
10 | Head Global Operations, Biolife Plasma Services | Reveal Email/Phone |
Takeda Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.1M | 65 | 30% | N/A | N/A |
#2 | $75.6M | 376 | 7% | N/A | N/A |
#3 | $23.9M | 119 | 13% | $35M | N/A |
#4 | $12.7M | 63 | -3% | N/A | N/A |
#5 | $5.4M | 27 | -25% | N/A | N/A |
#6 | $6M | 30 | -35% | N/A | N/A |
#7 | $6.6M | 33 | -8% | N/A | N/A |
#8 | $13.5M | 67 | -3% | N/A | N/A |
#9 | $186.3M | 927 | 19% | N/A | N/A |
#10 | $4.4M | 22 | -4% | N/A | N/A |
What Is Takeda?
In1781,Chobei Takeda I begins selling traditional Japanese and Chinese herbal medicines in Doshomachi , the medicine district of Osaka, Japan. Takeda’s founder gains a reputation for business integrity and quality products and services. These characteristics and values continue through the years and become embeded into our uncompromising corporate philosophy, which still guide us today.
keywords:N/AN/A
Total Funding
1027
Number of Employees
$200.6M
Revenue (est)
5%
Employee Growth %
$45.9B
Valuation
N/A
Accelerator
Takeda News
... ? The ouster of former Immunomedics exec Usama Malik created a CEO opening at Fore Biotherapeutics, which is taking aim at BRAF...
These data announcements follow completion of patient enrollment in Takeda's AURORA (TAK-620-302) study, focusing on LIVTENCITY for first-line...
These data announcements follow completion of patient enrollment in Takeda's AURORA (TAK-620-302) study, focusing on LIVTENCITY for first-line...
... ? The ouster of former Immunomedics exec Usama Malik created a CEO opening at Fore Biotherapeutics, which is taking aim at BRAF...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $384.5M | 1149 | 8% | N/A |
#2 | $201.6M | 1200 | 2% | N/A |
#3 | $312.5M | 1240 | N/A | N/A |
#4 | $268.9M | 1338 | 8% | N/A |
#5 | $300M | 1563 | 6% | N/A |